The increase in price target by Truist Securities suggests a modestly improved outlook for Nevro's stock. While the Hold rating indicates that the analyst does not see significant upside or downside in the near term, the raised target price could lead to a slight positive sentiment among investors, potentially causing a short-term increase in the stock price.